Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Published:2004-08-15 Issue:16 Volume:22 Page:3432-3433
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Creutzig U.¹,Kaspers G.J.L.²

Affiliation:

1. For the Acute Myeloid Leukemia Committee of the International Berlin-Frankfurt-Münster Study Group, Münster, Germany

2. For the Acute Myeloid Leukemia Committee of the International Berlin-Frankfurt-Münster Study Group, VU University Medical Center, Amsterdam, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.99.116

Reference2 articles.

1. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

2. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Patients With Relapsed Acute Promyelocytic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-06

2. Clinical analysis of 82 cases of acute promyelocytic leukemia with PML-RARα short isoform in children and adults;Frontiers in Oncology;2024-02-21

3. Refractory/Relapsed AML in Children and Evolution of Novel Therapies;Pediatric Oncology;2024

4. Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21);Hematology;2023-12-27

5. Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach;Indian Journal of Medical and Paediatric Oncology;2023-11-27